In vitro hematopoiesis in patients with malignant lymphoma during active disease and at complete clinical remission after chemotherapy

Leukemia and Lymphoma

Volumn 39, Issue 5-6, 2000, Pages 613-624

  Huerta Zepeda, A ^a   Talavera, A ^a   Aviles A ^a   Neri, N ^a   Mayani, H ^a  

^a HOSPITAL DE ONCOLOGÍA   (Mexico)

Author keywords

Bone marrow; Hematopoiesis; In vitro; Lymphoma; Progenitors; Stroma

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CYCLOPHOSPHAMIDE; CYTOKINE; ETOPOSIDE; INTERLEUKIN 6; PREDNISONE; STEM CELL FACTOR; TUMOR NECROSIS FACTOR ALPHA; VINCRISTINE;

ADULT; AGED; ARTICLE; BLOOD; BONE MARROW CELL; BONE MARROW CULTURE; CANCER CHEMOTHERAPY; CANCER REGRESSION; CELL ADHESION; CELL COUNT; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE ACTIVITY; ERYTHROID CELL; FEMALE; FIBROBLAST; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; LARGE CELL LYMPHOMA; LYMPHOMA; MALE; PARAMETER; PRIORITY JOURNAL; SUPERNATANT;

EID: 0034488866     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428190009113392     Document Type: Article

References (29)

1. A revised European-American classification of lymphoid neoplasms: A proposal from the international lymphoma study group
2. Lymphoma classification- The gap between biology and clinical management is closing
3. The role of clonal selection in the pathogenesis of an autoreactive human B cell lymphoma
4. Comparison of a second-generation combination chemotherapeutic regimen (m-BACOD) with a standard regimen (CHOP) for advanced diffuse non-Hodgkin's lymphoma
5. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma
6. GM-CSF instead of hematological support during high dose chemotherapy for refractory malignant lymphomas
7. Interferon alfa combined with cytotoxic chemotherapy for patients with non-Hodgkin's lymphoma
8. Maintenance therapy with interferon alfa 2b in patients with diffuse large cell lymphoma
9. Comparison of autologous bone marrow transplantation with sequential chemotherapy for intermediate and high grade non-Hodgkin's lymphoma in first remission
10. Molecular biology of non-Hodgkin's lymphoma
11. Rearrangements of the BCL6 gene and chromosome aberrations affecting 3q27 in 54 patients with non-Hodgkin's lymphoma
12. Deletions and rearrangements of cyclin-dependent kinase 4 inhibitor gene p16 are associated with poor prognosis in B cell non-Hodgkin's lymphomas
13. Expression in non-Hodgkin's lymphoma of the bcl-2 protein associated with the t(14;18) chromosomal translocation
14. Malignant and reactive cells from human lymphomas frequently express Fas ligand but display a different sensitivity to Fas-mediated apoptosis
15. Somatic Fas mutations in non-Hodgkin's lymphoma: Association with extranodal disease and autoimmunity
16. Dose escalation of epirubicin in the CEOP-BLEO regimen: A controlled clinical trial comparing standard doses for the treatment of diffuse large cell lymphoma
17. Modulation of erythropoiesis and myelopoiesis by exogenous erythropoietin in human long-term marrow cultures
18. Kinetics of hematopoiesis in Dexter-type long-term cultures established from human umbilical cord blood cells
19. Characterization of human bone marrow fibroblast colony-forming cells (CFU-F) and their progeny
20. Clonogenic cells in acute myeloblastic leukemia
21. Deficient proliferation of myeloid, erythroid and multipotent progenitor cells in long-term marrow cultures from patients with aplastic anemia treated with immunosuppressive therapy
22. Hematopoietic progenitor cells from patients with myelodysplastic syndromes: In vitro colony growth and long-term proliferation
23. Functional characterization of individual human hematopoietic stem cells cultured at limiting dilution on supportive marrow stromal layers
24. Haematopoietic abnormalities after autologous stem cell transplantation in lymphoma patients
25. Children in long-term remission after treatment for acute lymphoblastic leukemia show persisting haemopoietic injury in clonal and long-term cultures
26. The long-term effects of MVPP chemotherapy for Hodgkin's disease on bone marrow function
27. Cytokines released in vitro by stromal cells from autologous bone marrow transplant patients with lymphoid malignancy
28. Hematopoiesis: Long-term effects of chemotherapy and radiation
29. Haemopoiesis of transplanted patients with autologous marrows assessed by long-term marrow cultures